Known as GLP-1 agonists, new drugs could change how doctors treat obesity and, possibly, how the condition is more broadly understood. They could also raise healthcare spending substantially, posing a problem for insurers looking to control costs. INCLUDED IN THIS TRENDLINE – Novo obesity drug protects heart health in large trial – New kind of […]
Women’s health isn’t just having a moment — it’s finally burgeoning into a vibrant sector of healthcare poised for growth. Obstetrics, gynecology and fertility services dominated the landscape last year with record-smashing $3.3 billion in investments. INCLUDED IN THIS TRENDLINE – Women’s healthcare investments are hot. So where are the new menopause drugs? – With […]
Biopharma organizations are exploring artificial intelligence across multiple use cases: patient identification, data analysis, regulatory submissions, and beyond. Along the way, they’re seeing both short- and long-term success; some changes are fast, and others are slow. But as clinical trial leaders embrace the opportunities, they’re also contending with challenges—such as a criticism of algorithm bias […]
Shelf Data > Advertising Data
Shopkick recently surveyed consumers and found that 93% are still shopping in-store. Even after inflation, COVID-19, and the mass market situation, consumers are still vying to touch, feel, and buy inside the store…so what does that mean for you and your brand? Consumers are looking for brands that understand them, value them, and share in […]
Making the Connection: How Implementing Zero Trust Helps Prepare for Post-Quantum
In an era with evolving threats and increasingly sophisticated attacks, organizations are struggling to ensure their most valuable assets, systems, and data remain secure. In an effort to help provide direction, there has been an increasing amount of government action and regulation as of late — especially when it comes to the why and how […]
Implementation of Histopathology in Gastrointestinal Clinical Trials: Accelerate Time to Market for GI Clinical Trials
Our expert panel will discuss inflammatory bowel disease and NASH, two therapeutic areas that histopathology uses to determine eligibility and/or primary outcome measures. Our four experts will provide presentations on topics including: – Histopathology as a treatment target in IBD: Aspiration or Reality? – Measuring histopathology in IBD trials – Histopathology as a treatment target […]
While the COVID-19 pandemic sped up biomedical research in many ways, it also served as a catalyst of change in the clinical trial landscape. Although decentralized clinical trials (DCTs) skyrocketed along with new protocols and digital tools, there are still hurdles to overcome in affordability, trial participant recruiting, and more. In this Outlook Report, discover […]
Revealed: The Validation Industry Trends Impacting You Understand the trends influencing your validation program
The State of Validation is the world’s first comprehensive annual study and report of the validation industry. Each year, State of Validation measures and tracks a wide range of topics and metrics through surveys and interviews with validation professionals from across the globe, uncovering the trends, pitfalls, opportunities, and changes impacting validation programs. In this […]
Messaging in the New Era of Customer Engagement
Join our transformative webinar as we delve into the dynamic landscape of the WhatsApp Business Platform. Discover the many use cases for WhatsApp across verticals and regions. See how it seamlessly integrates into your enterprise tech stack, enriching your CRM, analytics, and more. Learn proven strategies to encourage customers to opt-in for meaningful interactions. Revolutionize […]
Cybersecurity for Energy on the Cloud: Questions We Hear, Answers We Provide
Many companies are moving toward an operational technology (OT) cloud. In the same way that digitization of offices made enterprise cloud possible, the digitization of OT environments now makes OT cloud a real possibility. As companies seek and discover ways to extract greater value from their OT data flows, many will determine that an OT […]